Related Articles

Cravatt, B.F., Giang, D.K., Mayfield, S.P., et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 83-87 (1996).

Di Marzo, V., Bisogno, T., Melck, D., et al. Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett 436 449-454 (1998).

Van Sickle, M.D., Oland, L.D., Ho, W., et al. Cannabinoids inhibit emesis through CB₁ receptors in the brainstem of the ferret. Gastroenterology 121 767-774 (2001).

Fowler, C.J., Jonsson, K., Tiger, G. Fatty acid amide hydrolase: Biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. Biochem Pharmacol 62 517-526 (2001).

Cravatt, B.F., Demarest, K., Patricelli, M.P., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98(16) 9371-9376 (2001).

Goparaju, S.K., Kurahashi, Y., Suzuki, H., et al. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis. Biochim Biophys Acta 1441 77-84 (1999).

Tsou, K., Nogueron, M.I., Muthian, S., et al. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254 137-140 (1998).

Bisogno, T., Katayama, K., Melck, D., et al. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells. Implications for cell proliferation and differentiation. Eur J Biochem 254 634-642 (1998).

Giang, D.K., Cravatt, B.F. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94 2238-2242 (1997).

Katayama, K., Ueda, N., Kurahashi, Y., et al. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochim Biophys Acta 1347 212-218 (1997).